Dihexa

Journal of Huntington's disease · 2024

Researchers studied the effects of a compound called PNB-0408 on rats that were exposed to a toxin mimicking Huntington's disease symptoms. They found that PNB-0408 did not prevent the negative effects on motor function, weight gain, or cognitive abilities caused by the toxin, suggesting it may not be an effective treatment for this condition in this model.

• PNB-0408 did not protect rats from weight loss induced by the toxin.
• The compound failed to improve motor function in rats exposed to the toxin.
• Cognitive abilities, including spatial learning and memory, were not preserved by PNB-0408 in this study.

Stem cell research & therapy · 2022

Researchers found a cost-effective method to produce liver cells from human stem cells using small molecules instead of expensive growth factors. This approach allows for the efficient generation of functional liver cells that can be used for research and potential therapies.

• The small-molecule cocktail CIP effectively induced the formation of definitive endoderm, a crucial step in liver cell development.
• Combining Vitamin C, Dihexa, and Forskolin successfully replaced growth factors to promote liver cell specification.
• The resulting liver cells displayed characteristics of mature liver cells and were capable of repopulating injured liver tissue in animal models.

Annals of medicine and surgery (2012) · 2021

Researchers investigated the effects of stem cells, Granulocyte-Colony Stimulating Factor (G-CSF), and Dihexa on limb recovery after nerve damage in rats. They found that these treatments significantly improved sensory and motor function in the affected limbs over time, suggesting their potential as supportive therapies for nerve repair.

• Sensory function in the rats returned to nearly normal levels by eight weeks after treatment.
• Motor function showed significant improvement when stem cells were combined with G-CSF or Dihexa.
• The recovery of nerve function varied, with some nerves regaining function more quickly than others.

Neuroscience and biobehavioral reviews · 2018

Researchers explored how certain brain peptides, specifically angiotensin IV and angiotensin-(1-7), affect cognitive functions in animals. They found that angiotensin IV showed positive effects on learning and memory tasks, particularly when administered close to the time of learning.

• Researchers observed that angiotensin IV improved performance in tests related to memory and learning in normal animals.
• In models of cognitive deficits, angiotensin IV and its analogs were found to have beneficial effects.
• Angiotensin-(1-7) demonstrated potential anti-dementia properties in the studies reviewed.

Current protocols in stem cell biology · 2016

Researchers observed a new method to create liver-like cells from human stem cells using small molecules instead of traditional growth factors. This approach allows for more efficient and reproducible production of these cells, which are important for studying liver diseases and testing new drugs.

• The study developed a protocol that uses small molecules to guide stem cells into liver-like cells.
• This method replaces the need for conventional growth factors, making the process more efficient.
• The resulting liver-like cells can be used for various applications in research and medicine.

Journal of Alzheimer's disease : JAD · 2015

Researchers reviewed a potential new treatment target for Alzheimer's disease, focusing on the hepatocyte growth factor/c-Met receptor system. They found that a compound called Dihexa may promote the formation of new synaptic connections and improve memory in animal models, suggesting it could be a promising approach for slowing the progression of Alzheimer's.

• Researchers observed that the c-Met receptor system plays a crucial role in neuron health and development.
• The compound Dihexa was shown to enhance the formation of new synaptic connections in animal models of Alzheimer's.
• Dihexa is orally active and can penetrate the blood-brain barrier, indicating its potential for memory improvement.

Frontiers in cellular neuroscience · 2015

Researchers studied a compound called Dihexa to see if it could protect sensory hair cells from damage caused by certain antibiotics. They found that Dihexa effectively shields these cells from toxicity, suggesting it may have potential for preventing hearing loss related to chemical exposure.

• Dihexa provides optimal protection to hair cells from aminoglycoside antibiotics at a concentration of 1 μM.
• The protective effect of Dihexa is linked to its activation of the hepatocyte growth factor (HGF) signaling pathway.
• Small chemical changes to Dihexa can significantly impact its protective abilities, highlighting the importance of its structure.

The Journal of pharmacology and experimental therapeutics · 2014

Researchers studied a compound called dihexa, derived from angiotensin IV, to understand its potential benefits for cognitive function. They found that dihexa activates a specific growth factor system in the brain, which promotes the formation of new connections between brain cells, suggesting it may have promising effects on memory and learning.

• Dihexa binds strongly to a growth factor called hepatocyte growth factor (HGF) and activates its receptor, c-Met.
• Both dihexa and another related compound promote the growth of new synapses in the brain, similar to HGF.
• The cognitive benefits of dihexa were blocked when HGF activity was inhibited, indicating its role in enhancing learning and memory.

Journal of receptor and signal transduction research · 2007

Researchers studied new dimeric versions of a hormone that targets melanoma cells to improve cancer diagnosis and treatment. They found that while these dimeric peptides showed strong binding to melanoma cells in lab tests, their effectiveness in living organisms was lower than expected, particularly due to increased uptake by the kidneys.

• Dimeric peptides showed higher binding affinity to melanoma cells in laboratory tests compared to a standard peptide.
• In living organisms, the dimeric peptides had lower tumor-to-kidney uptake ratios than the standard peptide.
• Increased kidney uptake of the dimeric peptides may limit their effectiveness for melanoma targeting.